Uriel Heresco-Levy Selected Research

Glycine (Aminoacetic Acid)

2/2015	Behavioral and cognitive effects of the N-methyl-D-aspartate receptor co-agonist D-serine in healthy humans: initial findings.
4/2013	Glycine site agonists of the N-methyl-D-aspartate receptor and Parkinson's disease: a hypothesis.
10/2009	Pilot controlled trial of D-serine for the treatment of post-traumatic stress disorder.
10/2007	The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments.
3/2007	High glycine levels are associated with prepulse inhibition deficits in chronic schizophrenia patients.
9/2005	Relation of plasma glycine, serine, and homocysteine levels to schizophrenia symptoms and medication type.
3/2005	D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia.
4/2004	Glycine and D-cycloserine attenuate vacuous chewing movements in a rat model of tardive dyskinesia.
2/2004	Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis.
1/2004	High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Uriel Heresco-Levy Research Topics

Disease

25	Schizophrenia (Dementia Praecox) 03/2015 - 09/2000
5	Tardive Dyskinesia 04/2013 - 02/2002
4	Psychotic Disorders (Schizoaffective Disorder) 09/2012 - 10/2003
4	Neurobehavioral Manifestations 06/2012 - 10/2003
4	Treatment-Resistant Schizophrenia 03/2005 - 03/2002
2	Mental Disorders (Mental Disorder) 02/2015 - 04/2002
2	Major Depressive Disorder (Major Depressive Disorders) 04/2013 - 07/2006
2	Parkinson Disease (Parkinson's Disease) 04/2013 - 05/2012
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 10/2009 - 12/2002
1	Autoimmune Diseases of the Nervous System 12/2013
1	Treatment-Resistant Depressive Disorder 04/2013
1	Cognitive Dysfunction 10/2007
1	Feeding and Eating Disorders (Eating Disorder) 12/2005
1	Bulimia (Binge Eating) 12/2005
1	Weight Gain 12/2005
1	Bipolar Disorder (Manic Depressive Psychosis) 09/2004
1	Nausea 01/2004
1	Asthma (Bronchial Asthma) 01/2004
1	Vomiting 01/2004
1	Hemorrhage 01/2004
1	Mood Disorders (Mood Disorder) 04/2002
1	Dyskinesias (Dyskinesia) 02/2002

Drug/Important Bio-Agent (IBA)

13	Antipsychotic Agents (Antipsychotics)IBA 04/2013 - 02/2002
12	Glycine (Aminoacetic Acid)FDA LinkGeneric 02/2015 - 12/2002
11	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 03/2015 - 09/2000
11	N-Methylaspartate (NMDA)IBA 12/2013 - 09/2000
10	Serine (L-Serine)FDA Link 03/2015 - 02/2004
7	Cycloserine (Seromycin)FDA Link 04/2013 - 03/2002
4	Olanzapine (Zyprexa)FDA Link 11/2013 - 03/2002
4	Glutamate Receptors (Glutamate Receptor)IBA 09/2012 - 12/2002
4	Phencyclidine (Angel Dust)IBA 09/2012 - 09/2000
4	Risperidone (Risperdal Consta)FDA LinkGeneric 05/2006 - 03/2002
4	Clozapine (Clozaril)FDA LinkGeneric 03/2005 - 10/2003
3	Ketamine FDA LinkGeneric 03/2007 - 09/2000
2	Neurotransmitter Agents (Neurotransmitter)IBA 12/2005 - 10/2003
2	Glutamic Acid (Glutamate)FDA Link 11/2005 - 10/2003
2	Amino Acids FDA Link 09/2005 - 04/2004
1	AntibodiesIBA 03/2015
1	AMPA Receptors (AMPA Receptor)IBA 12/2013
1	AntigensIBA 12/2013
1	Proteins (Proteins, Gene)FDA Link 12/2013
1	Antidepressive Agents (Antidepressants)IBA 04/2013
1	Excitatory Amino Acid AgentsIBA 10/2007
1	Sarcosine (Methylglycine)IBA 05/2006
1	Insulin-Like PeptidesIBA 12/2005
1	methyl 4-azidophenylacetimidate (APAI)IBA 12/2005
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 11/2005
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 09/2005
1	HomocysteineIBA 09/2005
1	Anticonvulsants (Antiepileptic Drugs)IBA 09/2004
1	Lamotrigine (Lamictal)FDA LinkGeneric 09/2004
1	Pharmaceutical PreparationsIBA 04/2004
1	Aspartic Acid (Aspartate)FDA Link 10/2003
1	Excitatory Amino AcidsIBA 10/2003
1	Fumigant 93 (D-D)IBA 12/2002
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2002
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 02/2002
1	Dopamine D3 ReceptorsIBA 02/2002
1	Dopamine (Intropin)FDA LinkGeneric 02/2002

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 10/2009 - 10/2003
3	Therapeutics 09/2009 - 09/2000
1	Secondary Prevention 01/2011
1	Acupressure (Shiatsu) 09/2009
1	Deinstitutionalization 01/2005
1	Hypnosis (Mesmerism) 01/2004
1	Operative Surgical Procedures 01/2004
1	Analgesia 01/2004